Leukocare Inc. is a biotechnology company specialized in the field of biopharmaceutical formulation
development. Operating at the interface of drug substance and drug product development, Leukocare
combines sound knowledge of formulation development with bioinformatics and artificial intelligence.
The formulation development approach consists of two elements: a library of up to 100 different
regulatory well-established and employed excipients and a rational development approach, which
employs statistical software and self-learning algorithms, as well as state of the art design of
experiment (DoE) matrices. By utilizing the artificial intelligence elements, Leukocare is able to
specifically combine excipients leading to stabilizing formulations tailored to the drug product’s needs.
Leukocare´s formulation technologies and expertise can be applied in the following core areas:
-Virus & Vaccines
-Biologics & Biosimilars
-Sterilization & Biofunctionalized Devices
Leukocare Inc. is a wholly owned subsidiary of Leukocare AG located in Martinsried/Munich, Germany.